Inhibikase Therapeutics
IKT
IKT
12 hedge funds and large institutions have $1.02M invested in Inhibikase Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$713K | |
| 2 | +$49.6K | |
| 3 | +$47.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$11.3K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.59K |
Top Sellers
| 1 | -$48.9K | |
| 2 | -$42.3K | |
| 3 | -$6.94K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.32K |
| 5 |
Renaissance Technologies
New York
|
-$726 |